Invited, % | Cut-offb | 10-year CVD risk treatment threshold for statins (statins assumed to increase diabetes risk) | ||||
---|---|---|---|---|---|---|
Net benefit for 10% threshold, £ | Net benefit for 15% threshold, £ | Net benefit for 20% threshold, £ | Net benefit for 25% threshold, £ | Net benefit for 7.5% threshold, £ | ||
8 | 0.1276 | 195 319 | 188 397 | 112 700 | 184 396 | 167 790 |
10 | 0.1142 | 188 736 | 183 987 | 128 576 | 196 675 | 179 743 |
13 | 0.0983 | 159 806 | 172 395 | 144 537 | 208 960 | 193 451 |
15 | 0.0896 | 128 521 | 171 427 | 151 326 | 218 406 | 199 252 |
20 | 0.0721 | 66 060 | 178 734 | 169 385 | 232 759 | 212 812 |
25 | 0.0590 | 48 489 | 181 858 | 176 995 | 238 400 | 215 999 |
30 | 0.0488 | 42 467 | 181 101 | 180 853 | 237 444 | 215 407 |
35 | 0.0406 | 36 219 | 174 050 | 178 669 | 231 126 | 210 097 |
40 | 0.0339 | 26 217 | 162 976 | 172 179 | 221 274 | 200 799 |
45 | 0.0283 | 12 992 | 150 559 | 165 075 | 207 209 | 187 863 |
50 | 0.0236 | −3225 | 132 937 | 156 436 | 191 749 | 172 612 |
8 | Cut-offb 0.1276 | 10-year CVD risk treatment threshold for statins (statins assumed not to affect diabetes risk) | ||||
420 494 | 414 083 | 347 839 | 245 586 | 193 065 | ||
10 | 0.1142 | 478 593 | 468 227 | 365 636 | 259 219 | 205 668 |
13 | 0.0983 | 550 404 | 527 239 | 382 343 | 273 194 | 220 312 |
15 | 0.0896 | 585 960 | 547 727 | 392 544 | 283 562 | 226 582 |
20 | 0.0721 | 647 281 | 574 502 | 408 967 | 299 397 | 240 952 |
25 | 0.0590 | 668 209 | 586 376 | 414 148 | 306 451 | 245 221 |
30 | 0.0488 | 675 641 | 590 219 | 412 947 | 306 481 | 245 441 |
35 | 0.0406 | 675 835 | 586 021 | 406 288 | 300 916 | 241 082 |
40 | 0.0339 | 670 013 | 577 154 | 397 083 | 291 742 | 232 443 |
45 | 0.0283 | 659 702 | 566 787 | 384 913 | 278 268 | 219 889 |
50 | 0.0236 | 645 655 | 550 856 | 368 788 | 263 606 | 205 184 |